ZA896851B - Use of ace-inhibitors - Google Patents

Use of ace-inhibitors

Info

Publication number
ZA896851B
ZA896851B ZA896851A ZA896851A ZA896851B ZA 896851 B ZA896851 B ZA 896851B ZA 896851 A ZA896851 A ZA 896851A ZA 896851 A ZA896851 A ZA 896851A ZA 896851 B ZA896851 B ZA 896851B
Authority
ZA
South Africa
Prior art keywords
vessel
prevention
ace
inhibitors
neointima
Prior art date
Application number
ZA896851A
Inventor
Hans Rudolf Baumgartner
Rudolf Baumgartner Hans
Jean-Paul Clozel
Clozel Jean-Paul
Fridolin Hefti
Hefti Fridolin
Markus Hosang
Hosang Markus
Herbert Kuhn
Kuhn Herbert
Rita Mueller
Mueller Rita
Jerry Powell
Powell Jerry
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of ZA896851B publication Critical patent/ZA896851B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

ACE inhibitors are able to suppress the formation of neointima and the reduction of the vessel volume owing to vessel wall thickening after a vessel injury. They are accordingly suitable for the treatment and prevention of neointima formation after vessel injury, in particular for the prevention of arterial restenosis after angioplasty or of vessel wall thickening after vascular surgery in arteries and veins.
ZA896851A 1988-09-14 1989-09-07 Use of ace-inhibitors ZA896851B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH342188 1988-09-14

Publications (1)

Publication Number Publication Date
ZA896851B true ZA896851B (en) 1990-06-27

Family

ID=4255625

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA896851A ZA896851B (en) 1988-09-14 1989-09-07 Use of ace-inhibitors

Country Status (13)

Country Link
EP (1) EP0363671B1 (en)
JP (1) JPH02121922A (en)
KR (1) KR900004337A (en)
AT (1) ATE100716T1 (en)
AU (1) AU625693B2 (en)
DE (1) DE58906814D1 (en)
DK (1) DK452089A (en)
ES (1) ES2061853T3 (en)
HU (1) HU206186B (en)
IE (1) IE892931L (en)
IL (1) IL91572A (en)
PT (1) PT91705B (en)
ZA (1) ZA896851B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3925759A1 (en) * 1989-08-03 1991-02-07 Thera Patent Verwaltungs Gmbh USE OF ACE INHIBITORS FOR ATHEROSKLEROSEPROPHYLAXE
DE3926606A1 (en) * 1989-08-11 1991-02-14 Hoechst Ag METHOD FOR THE TREATMENT OF CARDIALS AND VASCULAR HYPERTROPHY AND HYPERPLASIA
US5212165A (en) * 1989-10-23 1993-05-18 E. R. Squibb & Sons, Inc. Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor
US5061694A (en) * 1989-10-23 1991-10-29 E. R. Squibb & Sons, Inc. Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor
US5140012A (en) * 1990-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing pravastatin
CA2042159A1 (en) * 1990-05-31 1991-12-01 Miguel A. Ondetti Method for preventing onset of restenosis after angioplasty employing an ace inhibitor
CA2052014A1 (en) * 1990-10-19 1992-04-20 Henry Y. Pan Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor
ATE157871T1 (en) 1994-05-19 1997-09-15 Mitsubishi Chem Corp MEDICINAL PRODUCTS FOR THE THERAPEUTIC AND PROPHYLACTIC TREATMENT OF DISEASES CAUSED BY HYPERPLASIA OF SMOOTH MUSCLE CELLS
AU713530B2 (en) * 1995-03-24 1999-12-02 Molecumetics, Ltd. Beta-sheet mimetics and use thereof as protease inhibitors
AU708167B2 (en) * 1996-01-17 1999-07-29 Taiho Pharmaceutical Co., Ltd. Intimal hypertrophy inhibitors
EP1611886A3 (en) * 1999-08-30 2008-06-04 Sanofi-Aventis Deutschland GmbH Inhibitors of the renin-angiotensin system for the prevention of cardiovascular disorders
JP4904859B2 (en) * 2006-03-13 2012-03-28 大日本印刷株式会社 Printing unit and doctor blade polishing method
BRPI0621867A2 (en) * 2006-07-10 2011-12-20 Teva Pharma stable formulation consisting of a combination of a moisture sensitive drug and a second drug, and a process for its manufacture

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4105776A (en) 1976-06-21 1978-08-08 E. R. Squibb & Sons, Inc. Proline derivatives and related compounds
US4316906A (en) 1978-08-11 1982-02-23 E. R. Squibb & Sons, Inc. Mercaptoacyl derivatives of substituted prolines
AT377496B (en) 1981-06-19 1985-03-25 Voith Gmbh J M DEVICE FOR WINDING A TRACK OF GOODS ON A NEWLY INSERTED WRAPPING SLEEVE IN A DOUBLE-CARRIER ROLLING MACHINE

Also Published As

Publication number Publication date
DE58906814D1 (en) 1994-03-10
ES2061853T3 (en) 1994-12-16
HU206186B (en) 1992-09-28
EP0363671B1 (en) 1994-01-26
EP0363671A2 (en) 1990-04-18
HUT51148A (en) 1990-04-28
PT91705A (en) 1990-03-30
KR900004337A (en) 1990-04-12
DK452089A (en) 1990-03-15
IE892931L (en) 1990-03-14
AU4124089A (en) 1990-03-22
IL91572A0 (en) 1990-04-29
AU625693B2 (en) 1992-07-16
ATE100716T1 (en) 1994-02-15
PT91705B (en) 1995-05-31
EP0363671A3 (en) 1991-12-11
JPH02121922A (en) 1990-05-09
IL91572A (en) 1994-01-25
DK452089D0 (en) 1989-09-13

Similar Documents

Publication Publication Date Title
ZA896851B (en) Use of ace-inhibitors
SE8803472A (en)
HUP9802093A3 (en) Use of nitrogen-monoxyde for producing medicament useful for treatment of vascular thrombosis and restenosis
ATE406909T1 (en) PREVENTION AND TREATMENT OF PATHOLOGIES ASSOCIATED WITH ABNORMAL PROLIFERATION OF SMOOTH MUSCLE CELLS
ATE302599T1 (en) PREPARATIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF DISEASES OF THE BODY PASSAGES
ATE186460T1 (en) METHOD FOR PREVENTING RESTENOSATION AFTER RECANALIZATION OF BODY VESSELS
DK189886A (en) PROTECTED ARTICLE
NO992769D0 (en) Procedure for the treatment and prevention of heart failure and ventricular dilation
ATE253076T1 (en) ANTITHROMBOTIC DRUGS
AU6178094A (en) Polyurethane-coated intravascular prostheses (stents) for the treatment of blood vessel stenosis
DE69805199D1 (en) DESFERRI-EXOCHELIN FOR THE TREATMENT OF ATHEROSCLEROSE AND Vascular DAMAGE BY PREVENTING THE PROLIFERATION OF SMOOTH MUSCLE CELLS
DE69224983D1 (en) ANTI-GROWTH FACTOR ANTIBODIES IN THE TREATMENT OF Vascular Stenosis
NO924637D0 (en) PROCEDURE FOR PREVENTING REPEATING OF ARTERIES
EP0661981A1 (en) Use of hyaluronic acid and forms to prevent arterial restenosis.
EP0407229A3 (en) Laser catheter apparatus for use in arteries or other narrow paths within living organisms
UA37249C2 (en) Method for inhibiting stenosis and/or restenosis (variants), method for inhibiting restenosis upon surgery of coronary artery (variants), method for decreasing risk of non-acute ischemic complication upon reconstructive vascular surgery
DE29705218U1 (en) Partial sheath stent for the medical treatment of narrowed vessels, especially vascular areas with a branch
Elbert et al. Endoluminal stent coatings consisting of adsorbing copolymers reduce neointimal hyperplasia in the pig
CS846287A1 (en) Aid for vascular prostheses treatment of venous origin
FR2669826B1 (en) CATHETER FOR DILATION OF THE ARTERIES.
ITBS920070V0 (en) CATHETER FOR THE DESTRUCTION OF THE ARTERIES
BG101472A (en) Vascular transplant and method for its preparation